Avivagen Inc. filed its Annual on Feb 21, 2023 for the period ending Oct 31, 2022. In this report its auditor, UHY McGovern Hurley LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 283K | |
+11.04% | 11.42B | |
-4.29% | 5.57B | |
-0.50% | 4.94B | |
+3.57% | 4.58B | |
-21.31% | 2.66B | |
-22.67% | 1.14B | |
-20.67% | 918M | |
+28.84% | 913M | |
-16.12% | 891M |
- Stock Market
- Equities
- VIV Stock
- News Avivagen Inc.
- Avivagen Inc. Auditor Raises 'Going Concern' Doubt